GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MRT Inc (TSE:6034) » Definitions » Net-Net Working Capital

MRT (TSE:6034) Net-Net Working Capital : 円371.93 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is MRT Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

MRT's Net-Net Working Capital for the quarter that ended in Mar. 2024 was 円371.93.

The industry rank for MRT's Net-Net Working Capital or its related term are showing as below:

TSE:6034's Price-to-Net-Net-Working-Capital is ranked better than
83.43% of 175 companies
in the Healthcare Providers & Services industry
Industry Median: 7.03 vs TSE:6034: 2.28

MRT Net-Net Working Capital Historical Data

The historical data trend for MRT's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MRT Net-Net Working Capital Chart

MRT Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only 52.31 52.88 -3.63 41.86 390.28

MRT Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 382.23 439.09 416.65 411.79 371.93

Competitive Comparison of MRT's Net-Net Working Capital

For the Medical Care Facilities subindustry, MRT's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MRT's Price-to-Net-Net-Working-Capital Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MRT's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where MRT's Price-to-Net-Net-Working-Capital falls into.



MRT Net-Net Working Capital Calculation

MRT's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2022 is calculated as

Net-Net Working Capital(A: Dec. 2022 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(4897.583+0.75 * 1390.856+0.5 * 4.611-3674.242
-0-93.368)/5.57393
=390.28

MRT's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2024 is calculated as

Net-Net Working Capital(Q: Mar. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(3432.206+0.75 * 570.456+0.5 * 16.055-1711.81
-0-131.229)/5.44473
=371.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


MRT  (TSE:6034) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


MRT Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of MRT's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


MRT (TSE:6034) Business Description

Traded in Other Exchanges
N/A
Address
1-18-2 Kanan, 3rd Floor, Frame Kananzaka, Shibuya-ku, Tokyo, JPN, 150-0041
MRT Inc engages in the business of medical personnel placement services through Internet. It provides part-time and full-time physician referral services through physician referral site MedRT.com; as well as part-time job referral; job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.

MRT (TSE:6034) Headlines

No Headlines